Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Agrylin |
| Active Ingredient: | Anagrelide hydrochloride 0.61mg equivalent to anagrelide 0.5mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Shire New Zealand Limited |
| Manufacturer: | Patheon Manufacturing Services LLC, North Carolina, United States of America |
| Product: | Latanoprost |
| Active Ingredient: | Latanoprost 0.05mg/mL |
| Dosage Form: | Eye drops, solution |
| New Zealand Sponsor: | Teva Pharma (New Zealand) Limited |
| Manufacturer: | FDC Limited, Aurangabad, India |
Dated this 31st day of January 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).